On Aug. 10, the White House released an executive order directing a reassessment that would reduce routine childhood vaccine recommendations. Although the order does not explicitly name autism, President Donald Trump has publicly attributed an increase in autism diagnoses to childhood vaccines. The White House and HHS have not provided detailed public evidence showing which vaccines, if any, the administration believes are implicated.
HHS framed the action as building on a January agency announcement to reassess the U.S. vaccine schedule and to consider peer-country guidance. However, no peer country reportedly separates the measles, mumps, and rubella vaccine (MMR) in the way the president has ordered.
Health Secretary Robert F. Kennedy Jr. has overseen a high-priority, multimillion-dollar research effort to identify causes of autism. According to reporting, the project has been conducted with substantial secrecy: there have been few public status updates and limited disclosure about which federal agencies or career scientists are leading or participating.
Kennedy has brought into the project several longtime allies and vaccine critics. His senior adviser William “Reyn” Archer III reportedly has spent months acquiring Americans’ medical records for review. The National Institutes of Health under the administration has also issued roughly $50 million in grants to university researchers studying autism, though many of those studies are expected to take years to complete.
In January, Kennedy also replaced membership on the Interagency Autism Coordinating Committee, appointing 21 new members that include parents of autistic children, vaccine skeptics, and others aligned with his priorities. The committee has met only once during the current term and later released a 336-page strategic plan that questions whether federal research has overemphasized genetic explanations.
Decades of scientific research identify genetics as a leading contributor to autism, with environmental factors also implicated. Examples of environmental contributors cited in the reporting include prenatal exposure to pollution, parental age (including older paternal age), and maternal health. Increased autism diagnoses over recent decades have been attributed in part to enhanced awareness, expanded diagnostic criteria, improved screening, and demographic factors.
Federal scientific leaders have acknowledged that there is no settled, single explanation for the observed increase in autism diagnoses. NIH Director Jay Bhattacharya — interviewed about the administration’s work — said he does not know the answer to why diagnoses have risen and that no conclusion had been reached.
The administration’s approach has included personnel changes, grant allocations, and policy direction. Key actions reported include:
HHS has stated it will examine “every biologically plausible hypothesis” and make findings available as they are ready.
Kennedy has advanced several specific claims linking various exposures or interventions to autism. Reporting notes multiple instances where those claims have been challenged by peer-reviewed research or broader scientific review:
The reporting also notes that Kennedy canceled millions in funding for ongoing research searching for autism causes, including potential environmental sources.
Multiple scientists, advocacy groups, and career federal researchers report the administration’s research process has been opaque. Prominent autism advocacy organizations and leading researchers say they have not been consulted. Requests for meetings with Kennedy have reportedly gone unanswered, and officials familiar with the matter say career scientists were not involved in shaping the effort in a publicly visible way.
Critics describe the project as unusually closed and have compared its secrecy to historical, high-security efforts. Observers expressed concern that the reconstituted advisory committee and other personnel choices reflect a tilt toward vaccine-skeptical viewpoints.
The executive order and public rhetoric come amid a contemporaneous rise in measles infections and ongoing public health concerns about vaccine-preventable diseases. The directive’s timing — less than 90 days before midterm elections and following polling warnings about anti-vaccine rhetoric — has prompted commentary about political motivations and electoral risk.
Medical groups, practicing clinicians, and public health analysts have been puzzled by the administration’s stance and its willingness to promote contested claims about vaccines and autism. White House officials have not publicly detailed what research, if any, directly informs the president’s claims linking vaccines to autism.
As of the reporting, Kennedy’s research had not yielded conclusive evidence linking vaccines to autism, and senior agency officials acknowledged no definitive answers. NIH-funded studies will take time to report results, and the administration has not disclosed which specific vaccines, if any, it considers potential causes.
Key unanswered questions from the reporting include which vaccines the president believes are implicated, what specific evidence or analyses underlie the administration’s policy changes, and when, if ever, the research led by Kennedy will produce publicly available, peer-reviewed findings. Critics continue to demand greater transparency and engagement with the broader scientific community to ensure research and policy decisions are guided by rigorous evidence.